Bristol Myers Squibb Gets CHMP Opinion for Breyanzi in Lymphoma
Recommendation based on the Phase 2 TRANSCEND FL study in which 97.1% of patients responded to Breyanzi, with 94.2% of patients achieving complete response Across clinical...
Category : Healthcare and Pharmaceutical
Solara Mental Health Supports HRV Biofeedback Research for Vets
Solara Mental Health proudly recognizes the doctoral research of Moe Fathi, Ph.D., from the California School of Professional Psychology, Alliant International University. His study, “The Use of...
Immunome Closes Upsized Offering, Underwriters Exercise Option
Immunome, Inc. (“Immunome”) (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced the closing of its underwritten public...
Inhalon Biopharma’s Inhaled RSV Antibody to Enter Trials
New at-home RSV treatment represents a potential breakthrough in addressing the burden of respiratory diseases, especially in vulnerable pediatric and elderly populations nhalon Biopharma, Inc. (Inhalon),...
Avanzanite Bioscience Appoints Chief Financial Officer
Avanzanite Bioscience B.V., a pioneering commercial-stage specialty pharmaceutical company advancing life-changing medicines for rare disease patients across Europe, announces today the appointment of Abdelghani (Abdel)...
KORU Medical Announces Phase III Trial for New Nephrology Drug
KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and...
Daiichi Sankyo Appoints Hiroyuki Okuzawa as Chief Executive Officer
Daiichi Sankyo Company, Ltd (TSE: 4568) has appointed Hiroyuki Okuzawa, 62, to succeed Sunao Manabe, DVM, Ph.D. as Chief Executive Officer (CEO), effective April 1,...
Vertex Announces CASGEVY® Reimbursement for SCD in England
– Agreement means eligible sickle cell disease (SCD) patients in England now have access to CASGEVY – – Agreement for CASGEVY in transfusion-dependent beta thalassemia...
GE HealthCare Invests $138M in Cork Facility for Contrast Media
GE HealthCare (Nasdaq: GEHC) today announced a $138 million investment to expand its Carrigtohill, Cork contrast media fill and finish manufacturing site in Ireland. A...
Meiji Seika Pharma Gets Approval for Domestic KOSTAIVE® Production
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan, President and Representative Director: Daikichiro Kobayashi) announced today that it has received approval for a partial amendment...
Ferrer recognized for best-in-class ethics and compliance program
Ferrer has achieved Compliance Leader Verification™, the prestigious recognition granted by Ethisphere, which distinguishes the pharmaceutical company as a global leader in upholding ethical and...
Osta Therapeutics adds two experts to tackle antibiotic resistance
Osta Therapeutics, a biotechnology company developing smart drugs to fight antibiotic resistance, today announced the appointments of Dr. Gilles Courtemanche as Senior Scientific Advisor and...
Nomi Health named ACAP preferred vendor to boost health equity
Nomi Health Joins the Association for Community Affiliated Plans to Support Not-for-Profit Safety Net Health Plans Nomi Health, a leading direct healthcare company, today announced...
Owkin doses first patient in AI-optimized trial of OKN4395.
Owkin, the first end-to-end AI-biotech that uses agentic AI to revolutionize drug discovery, development, and diagnostics, today announced that the first patient has been dosed...
Kyowa Kirin, Swixx expand POTELIGEO® access in CEE
Kyowa Kirin International (KKI), a wholly owned subsidiary of Kyowa Kirin Co. Ltd., and Swixx BioPharma AG today announced that the Croatian National Health Insurance...